At a glance
ClinicalIndex Comparison RecordN/ACompleted· 338 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vascular Risk After Kidney Transplantation
In Brief
An observational study for Cardiovascular Disease and 4 related conditions. Completed, enrolled 338 participants across 1 site.
Detailed Summary
Hypothesis: Nontraditional risk factors, such as inflammation, vitamin D deficiency, elevated PTH, insulin resistance, homocysteine, or uric acid, contribute to cardiovascular disease progression after kidney transplant. The purpose of this study is to evaluate which traditional and nontraditional cardiovascular disease risk factors best predict progression of cardiovascular disease (CVD) using carotid intima media thickness performed by ultrasound, in kidney transplant patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Disease, Chronic Kidney Disease, Diabetes, Vitamin D Deficiency, Hyperparathyroidism
CountriesUnited States
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2006
First PostedSep 2006
Primary CompletionJul 2012
Study CompletionJun 2023
TodayJul 2026
First PostedSep 11, 2006
Enrollment StartApr 1, 2006
Primary CompletionJul 26, 2012
Study CompletionJun 20, 2023
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 19.8 years ago